PLAY PODCASTS
Immunotherapy for Advanced HCC: Case Series
Episode 59

Immunotherapy for Advanced HCC: Case Series

Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations for hepatologists, oncologists, and other healthcare professionals in the contemporary use of immune checkpoint inhibitors for treating specific patient cases with advanced hepatocellular carcinoma.

Decera Clinical Education Oncology Podcast · Lipika Goyal MD, Amit G. Singal MD MS

May 17, 202125m 37s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations key considerations for hepatologists, oncologists, and other healthcare professionals in the contemporary use of immune checkpoint inhibitors for treating specific case patients with advanced hepatocellular carcinoma, including:

  • First-line systemic treatment for a patient with Child-Pugh A liver function and no elevated bleeding risk
  • First-line systemic treatment for a patient with Child-Pugh A liver function and elevated bleeding risk
  • First-line systemic treatment for a patient with Child-Pugh B liver function
  • Second-line systemic treatment for a patient previously receiving atezolizumab plus bevacizumab
  • Management of immune-mediated hepatitis in a patient with HBV receiving an immune checkpoint inhibitor

Presenters:

Amit G. Singal, MD, MS
Chief of Hepatology
Medical Director, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Lipika Goyal, MD
Lead of the Liver Cancer Research Program
Assistant Professor of Medicine
Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Content based on an online CME program supported by an educational grant from Genentech, a member of the Roche Group.

Link to full program:
https://bit.ly/39V6s72


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

amit singalnivolumabpembrolizumabgastrointestinal cancerhepatocellular carcinomaimmune checkpoint inhibitorsliver canceripilimumabbevacizumabimmunotherapygi cancerhccatezolizumablipika goyal